Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting

Date : 05/08/2019 @ 11:04PM
Source : GlobeNewswire Inc.
Stock : Aeterna Zentaris Inc. (AEZS)
Quote : 3.02  0.27 (9.82%) @ 12:59AM

Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting

Aeterna Zentaris Inc. (NASDAQ:AEZS)
Historical Stock Chart

2 Months : From Apr 2019 to Jun 2019

Click Here for more Aeterna Zentaris Inc. Charts.

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) announced today at its annual and special shareholders’ meeting held on May 8, 2019, that the individuals noted below were elected as directors of the Company. The report on proxies provided by the Company’s transfer agent indicated the following:

Name of NomineeVotes For%Votes Withheld%
Carolyn Egbert1,867,04991.19180,3248.81
Gérard Limoges1,861,38990.92185,9849.08
Robin Smith Hoke1,864,98191.09182,3928.91
Brent Norton1,861,56390.92185,8109.08
Jonathan Pollack1,860,31790.86187,0569.14

The Company would like to extend its sincere thanks and best wishes to Juergen Ernst, who has served on the board of directors since 2005.

The Company reports the re-appointment of PricewaterhouseCoopers LLP as the Company's independent auditor.

The Company’s shareholders approved an ordinary resolution approving the amended and restated shareholder rights plan.

Further, the Company passed a special resolution to amend the articles of the corporation to change the province in which its registered office is situated from Quebec to Ontario.

For full voting details please see the voting results of Aeterna Zentaris Inc. as filed on SEDAR at www.sedar.com and EDGAR at www.sec.gov.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on commercializing novel pharmaceutical therapies, principally through out-licensing arrangements. Aeterna Zentaris is a party to a license and assignment agreement with Novo Nordisk A/S to carry out development, manufacturing, registration and commercialization of Macrilen™ (macimorelin) in the United States and Canada. For more information, visit www.zentaris.com.

Contacts:

Aeterna Zentaris Inc.Leslie AuldChief Financial OfficerIR@aezsinc.com (843) 900-3211

Latest AEZS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.